Gao, Q, Liang, WW, Foltz, SM, Mutharasu, G, Jayasinghe, R, Liu, Y, Zhang, W, Akbani, R, Broom, BM, Ju, Z, Kanchi, RS, Korkut, A, Li, J, Liang, H, Ling, S, Liu, W, Lu, Y, Mills, GB, Uppore Kukkillaya, AR, Weinstein, JN, Zhang, J, Liu, X, Wang, L , Carvalho, AL, Fregnani, JG, Reis, RV, Scapulatempo, CN, Ajani, JA, Behrens, MC, Bondaruk, J, Broaddus, R, Czerniak, BA, Esmaeli, B, Fujimoto, J, Gershenwald, JE, Guo, CC, Lazar, A, Logothetis, CJ, Meric-Bernstam, F, Moran, C, Ramondetta, LM, Rice, DC, Sood, AK, Tamboli, P, Thompson, T, Troncoso, P, Tsao, A, Wistuba, II, von Deimling, A, Chen, K
Lipid peroxidation, associated with 15-LOX-1 activity, shows potential in cancer therapy, in contrast to the pro-tumoral effects of 5-LOX and 12-LOX (Clemente et al., 2020)
In terms of weight loss, the GLP-1 hormone slows our digestion down, releasing less glucose from the food we eat into our digestion
and the MT + SNP treatment reduced total antioxidant capacity by 17% on 1 d and increased it by 13%131% on 2d4 d (Fig